Objective:

To address concerns regarding the World Professional Association for Transgender Health (WPATH) and its clinical guidelines for pediatric gender medicine.

Approach:

Key Findings:

• HHS identified significant weaknesses in the evidence base and guideline-development process of WPATH's Standards of Care Version 8.
• Concerns were raised about conflicts of interest and a lack of methodological rigor in WPATH's guidelines.
• The HHS report noted a pattern of circular referencing and mutual endorsement among guideline-producing organizations.

Interpretation:

Limitations:

• The review did not provide a comprehensive analysis of all pediatric gender medicine practices.
• The findings are based on the HHS's assessment and may not reflect the views of all stakeholders in the field.

Conclusion:

HHS is committed to promoting evidence-based medicine and transparency in clinical practice guideline development.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.